Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthopediatrics (KIDS) EPS (Weighted Average and Diluted) (2019 - 2026)

Orthopediatrics' quarterly EPS (Weighted Average and Diluted) came in at -$0.45 in Q1 2026, up 2.17% year-on-year from -$0.44 in Q1 2025, and down 4.65% quarter-over-quarter from -$0.43 in Q4 2025.

Orthopediatrics has reported EPS (Weighted Average and Diluted) for 8 years, with the latest figure at -$0.45 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 2.17% year-over-year to -$0.45; the trailing twelve-month figure through Mar 2026 stood at -$1.68 (up 4.55% YoY), and the FY2025 full-year result was -$1.69, down 3.05% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.45, down from -$0.43 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.87 in Q3 2022, with the low at -$0.7 in Q4 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.28, with a median of -$0.34 recorded in 2024.
  • Peak annual rise in EPS (Weighted Average and Diluted) reached 890.91% in 2022, while the deepest fall reached 10001.74% in 2022.
  • Tracing KIDS's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.37 in 2022, then advanced by 21.62% to -$0.29 in 2023, then plunged by 141.38% to -$0.7 in 2024, then soared by 38.57% to -$0.43 in 2025, then fell by 4.65% to -$0.45 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$0.45 (Q1 2026), -$0.43 (Q4 2025), and -$0.5 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Orthopediatrics 394.83 Mn 346.02 Mn 43.39 Mn -0.45

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.45
Dec 31, 2025 -0.43
Sep 30, 2025 -0.50
Jun 30, 2025 -0.30
Mar 31, 2025 -0.46
Dec 31, 2024 -0.70
Sep 30, 2024 -0.34
Jun 30, 2024 -0.26
Mar 31, 2024 -0.34
Dec 31, 2023 -0.29
Sep 30, 2023 -0.20
Jun 30, 2023 -0.13
Mar 31, 2023 -0.30
Dec 31, 2022 -0.37
Sep 30, 2022 0.87
Jun 30, 2022 -0.02
Mar 31, 2022 -0.47
Dec 31, 2021 0.00
Sep 30, 2021 -0.11
Jun 30, 2021 -0.19
Mar 31, 2021 -0.54
Dec 31, 2020 -0.73
Sep 30, 2020 -0.24
Jun 30, 2020 -0.54
Mar 31, 2020 -0.30
Dec 31, 2019 -0.37